expanding access to treatment for opiate addiction ......expanding access to treatment for opiate...

22
Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise Lodge Addiction Treatment Hospital, NM Department of Health; and UNM Project ECHO Addiction Treatment Program

Upload: others

Post on 12-Jun-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

Expanding access to treatment for opiate addiction: Successes and Barriers

Miriam Komaromy, MDMedical Director,Turquoise Lodge Addiction Treatment Hospital, NM Department of Health; and

UNM Project ECHO Addiction Treatment Program

Page 2: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

SAMHSA Nat Survey Drug Use and Health 2005, 2006

Misuse of prescribed opioids is common…..

Page 3: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

% of 12th graders reporting non-medical use in past year, 2007

0 2 4 6 8 10 12

VicodinOxyContin

NIDA Monitoring the Future Study 2007

Page 4: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

Unintentional overdose deaths involving opioid analgesics now exceed the sum of deaths involving heroin or cocaine

0

2,000

4,000

6,000

8,000

10,000

12,000

14,000

'99 '00 '01 '02 '03 '04 '05 '06 07

Nu

mb

er o

f d

eath

s

Source: National Vital Statistics system, multiple cause of death dataset, Len P aulozzi, CDC 2010

Opioid analgesic

Cocaine

Heroin

4

Page 5: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

New Mexico has a huge opioid addiction problem

NM had the 2nd highest drug-induced death rate in the US in 2005, 20.9 deaths per 100 K persons, compared to the US rate of 11.2. 2 NM counties were among the top 25 in the US for drug-induced poisoning deathThe total unintentional drug overdose death rate in NM increased by 180% 1990-2005 (5.6 to 15.5 per 100K ) During 1990-2005, the 196% increase in single drug category overdose death was driven by prescription opioids alone and heroin alone

Shah NG, NM Epidemiology Report 2008Shah NG, Addiction 2008

Page 6: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

In response to the problems of opiate and alcohol addiction, and the highest rates of Hepatitis C infection in the US,

we launched a program in 2006 to expand access to addiction treatment in

our large, poor, rural state:

Project ECHO

Page 7: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

What is Project ECHO?

Extension for Community Healthcare OutcomesFounded by Dr. Sanjeev Arora at the University of NM with an initial focus on expanding access to hepatitis C treatmentThe mission of Project ECHO is to develop the capacity to safely and effectively treat chronic, common and complex diseases in rural and underserved areas, and to monitor outcomes.

Page 8: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

Project ECHO: methodsUse technology to leverage scarce healthcare resources: tele / video conferencing with Primary Care Providers (PCPs) in underserved areasCase-based learning: PCPs present cases on weekly statewide teleconference, and receive feedback from specialists at UNM and other PCPsDisease management model improves outcomes by sharing best practices“Learning loops” help PCPs develop confidence and expertise of their own, become resources in their own communitiesForce Multiplier

Page 9: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise
Page 10: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

How does ECHO work for Addiction Treatment?

Because of huge opiate problem in NM, focus has been on training PCPs to treat with buprenorphineRaise interest/awareness via grand rounds presentations around state8-hour tailored Buprenorphine trainings in-person and via videoconferenceWeekly 2-hour telehealth conference since ’06, includes counselors as well as medical providers

Page 11: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

Observational data on Buprenorphine effectiveness Increasing use of buprenorphine in

France associated with 1,2

– Decrease in arrests for heroin (77% decline since 1995)

– Decrease in overdose deaths (81% decline since 1995)

1. Auriacombe 2004, Am J Addict;13.2. Lepere 2001, Ann Med Interne (Paris);152 Suppl 3.

Page 12: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

1202000

564

Page 13: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

Buprenorphine treatment outcomes at 6 months

Heroin users Pain pill usersMethadone(data from literature review)

Retention in treatment 67% * 77% 53-63%

Abstinence (self-reported) 70% 73%

30 day illicit drug use (self-reported)

1.2 days 3-7 days

*14% of pts reported they had already completed treatment by 6 months

SAMHSA evaluation of the Impact of the DATA waiver program, Final Summary Report. March 2006. http://buprenorphine.samhsa.gov/FOR_FINAL_summaryreport_colorized.pdf

Page 14: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

Criminal Activity past 30 days in buprenorphine-treated patients(self- reported)

Street drug acquisition

Drug dealing

Prescription fraud

Other crimes

Baseline13 days 16% 10% 10%

After 6 months of treatment

1.7 days 3% 1% 2%

SAMHSA evaluation of the Impact of the DATA waiver program, Final Summary Report. March 2006. http://buprenorphine.samhsa.gov/FOR_FINAL_summaryreport_colorized.pdf

Page 15: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

RCT of buprenorphine

40 Heroin addicts Buprenorphine 8mg/day vs taper + placeboAll received counseling, groupsFollowed for 1 year

Kakko et al, Lancet 2003

Buprenor-phine

Placebo

Retained at one year

70% 0

Died 0 20%

Page 16: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

Buprenorphine vs Methadone

Like Methadone…• Reduces IDU• Retains pt in

treatment• Decreases

craving• Stops withdrawal• Costs $ 5-13 per

day

Unlike Methadone….• Low potential for OD• No sedation• Easy taper/detox• Prescribed in MD

office• Offers access in

small rural communities

Page 17: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise
Page 18: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

Ranking has increased from 13th to 5th in the US since the start of ECHO: buprenorphine providers per capita

State Rank 2005 Physicianscertified 2005

Rank 2009

Physicians certified 2009

VT 1 31 1 160

ME 2 41 2 241

DC 9 81

MA 6 100 3 877

MD 10 82 4 749

NM 13 21 5 258 (*156 by ECHO)

RI 4 20 6 127

NY 7 292 7 2156

CT 3 67 8 382

PA 8 185 9 1200

AK 6 17 10 62

CSAT database of certified MDs 2005, 2009

Page 19: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

Survey of ECHO bup prescribers:What has been the impact of prescribing buprenorphineon your clinical practice?

Question MeanMy ability to help opiate-addicted patients 6.5

My satisfaction with clinical practice 6.2

The clinic staff’s satisfaction with our practice 5.6

My practice partners’ satisfaction with our practice 5.9

My ability to have a positive impact on my community 6.4

My interest in treating patients with opiate addiction 6.4

My interest in treating patients with other addictions 6.0

My professional reputation in my community 5.5

Response choices from 0=strongly negative impact, 4=no impact,5=somewhat positive, 7=strongly positive impact

N=51, survey response rate 70%, 2010

Page 20: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

Why do so few trained prescribers actually prescribe?

Nationally, only ¼ of buprenorphine-certified physicians actually prescribeOnly 1/3 of doctors we train actually prescribe buprenorphineClinic administrators are often opposed to buprenorphine prescribingWhy?

Page 21: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

Huge reimbursement barriers for NM PCPs who wish to treat opiate addictionMedicaid/Saluds will pay for Suboxone prescribed by PCP (with Prior Auth)However, they won’t pay PCP for the visitOptum Health will pay for Suboxone and for office visit, but only if it is prescribed by a psychiatristThere are very few Suboxone-certified psychiatrists in NM, and virtually none in rural areasMost poor New Mexicans are not covered by either of these programs, and can’t afford >$400/month for SuboxoneContrast with Vermont

Page 22: Expanding access to treatment for opiate addiction ......Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise

How to contact us

Miriam Komaromy, [email protected]

Bonnie Kraybill Mount, [email protected]

Upcoming ECHO buprenorphine training:Albuquerque, Saturday January 22